Phoenix Pharmaceuticals, Inc.
Records under this name other than the patents Phoenix Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 2 of 2 · Back to Phoenix Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,835,806 | Cell Growth Regulation System Term ended Term ended Feb 26, 2022 · High confidence | Term ended | Term ended Feb 26, 2022 | High confidence |
| US 7,462,355 | Angiogenesis Regulation System Lapsed on the fee record Ended Dec 9, 2020 · High confidence | Lapsed on the fee record | Ended Dec 9, 2020 | High confidence |